Recently, I wrote a blog about the importance of Environmental, Social and Corporate Governance (ESG) and why the genomics industry […]
Janina Jeff is an American geneticist and Staff Bioinformatics Scientist at Illumina. Jeff is particularly interested in identifying genetic variants […]
Illumina has finalised its acquisition of cancer screening company Grail, despite both antitrust concerns from the EU and a pending […]
Illumina’s systems employ short-read sequencing techniques, which has been the predominant NGS technology for the last decade. The company has […]
In a recent study, researchers integrated existing genomic, epigenomic and transcriptomic data to generate novel insights into the aetiology of […]
Following the first “Start-up Zone” at The Festival of Genomics & BioData last week, we had the chance to catch […]
Arunas Leipus, Senior Product Manager for NGS at Thermo Fisher presented at the Festival of Genomics 2020.
The United Arab Emirates (UAE) is famous for the opulent city of Dubai, where you’ll find the world’s tallest building, […]
A multi-omics approach involves the combining of different “omics”: genomics, epigenomics, transcriptomics, and proteomics. The simultaneous study of each “omic” […]
The number of different technologies and hardware platforms that are now on the market can be overwhelming. Each comes with […]
